Cargando…
Ester-Modified Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents
Organometallic iridium complexes are potent anticancer candidates which act through different mechanisms from cisplatin-based chemotherapy regimens. Here, ten phosphorescent cyclometalated iridium(III) complexes containing 2,2′-bipyridine-4,4′-dicarboxylic acid and its diester derivatives as ligands...
Autores principales: | Wang, Fang-Xin, Chen, Mu-He, Hu, Xiao-Ying, Ye, Rui-Rong, Tan, Cai-Ping, Ji, Liang-Nian, Mao, Zong-Wan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154195/ https://www.ncbi.nlm.nih.gov/pubmed/27958338 http://dx.doi.org/10.1038/srep38954 |
Ejemplares similares
-
Cyclometalated iridium(iii) complexes as lysosome-targeted photodynamic anticancer and real-time tracking agents
por: He, Liang, et al.
Publicado: (2015) -
Targeting cancer cell metabolism with mitochondria-immobilized phosphorescent cyclometalated iridium(iii) complexes
por: Cao, Jian-Jun, et al.
Publicado: (2017) -
Inhibition of autophagic flux by cyclometalated iridium(iii) complexes through anion transportation
por: Chen, Mu-He, et al.
Publicado: (2019) -
Oncosis-inducing cyclometalated iridium(iii) complexes
por: Guan, Ruilin, et al.
Publicado: (2018) -
Lysosomal Targeted Cyclometallic Iridium(Ⅲ) Salicylaldehyde-Coumarin Schiff Base Complexes and Anticancer Application
por: Xu, Ruixi, et al.
Publicado: (2022)